0shopping bag

LOWEST PRICE - PRICE BEAT GUARANTEE*

CUSTOMS CLEARED GUARANTEED DELIVERY*

AVAILABLE FOR RESEARCH & SCHOLARLY STUDIES ALSO*

*see FAQs / Terms & Conditions for Details

BLOGS & NEWS

The Effectiveness of Brigatinib over Crizotinib for Treating Non Small Cell Lung Cancer

The Effectiveness of Brigatinib over Crizotinib for Treating Non Small Cell Lung Cancer

Brigatinib / Alunbrig is a cancer medication belonging to the class of anaplastic lymphoma kinase inhibitor or ALK. It has been proven to be efficient in treating non-small cell lung cancer or NSCLC that is ALK positive. ...

Read More
Breast Cancer Medication Palbociclib may be highly effective against some forms of Pancreatic Cancer

Breast Cancer Medication Palbociclib may be highly effective against some forms of Pancreatic Cancer

Palbociclib (brand Ibrance/Palpbace) is medication approved by the FDA and other regulatory bodies in different countries for treating breast cancers that are HER2-negative or ER-positive. ...

Read More
Palbociclib Improves Survival in Women with Breast Cancer

Palbociclib Improves Survival in Women with Breast Cancer

Palbociclib (Brand Ibrance) is a targeted therapy (CDK 4/6 inhibitor) manufactured by Pfizer which is used for the treatment of HER2-negative and HR-positive breast cancer. Ibrance is marketed by Pfizer in India under the Brand name of PALBACE. ...

Read More
Approval of Lenvatinib as a therapy medication for Advanced Kidney Cancer

Approval of Lenvatinib as a therapy medication for Advanced Kidney Cancer

Lenvatinib commonly known as Lenvima (manufactured by Eisai), was approved by US Food and Drug Administration in 2016 for the treatment of advanced kidney cancer. This medication has been approved solely for the patients whose cancer has progressed even after receiving treatment from medications which blocks the tumour growth. ...

Read More
FDA approves Lenvatinib for the treatment of thyroid cancer

FDA approves Lenvatinib for the treatment of thyroid cancer

In early 2015, US Food and Drug Administration or FDA approved Generic Lenvatinib / Brand Lenvima for treating patients diagnosed with thyroid cancer. ...

Read More
Gastric Cancer Treatment with Docetaxel

Gastric Cancer Treatment with Docetaxel

What is Docetaxel? Docetaxel brand name Taxotere is an anti-cancer chemotherapy medication which is classified as an antimicrotubule agent. This medication has been in the market since 2004, and has shown tremendous results among patients. ...

Read More
How Docetaxel is used for the Treatment of Different Cancers

How Docetaxel is used for the Treatment of Different Cancers

Docetaxel (Brand Taxotere) is a chemotherapeutic medication that is prescribed for the treatment of several kinds of cancers including head & neck cancer, prostate cancer, etc. ...

Read More
Can Entecavir lower the risk of Hepatocellular carcinoma in Hepatitis C patients

Can Entecavir lower the risk of Hepatocellular carcinoma in Hepatitis C patients

Hepatocellular Carcinoma or HCC is the commonly diagnosed form of liver cancer. It is most likely to occur in people with a chronic liver disease such as hepatitis C infection. ...

Read More
Hepatitis B treatment with Entecavir

Hepatitis B treatment with Entecavir

What is Baraclude/Entecavir? Baraclude (generic Entecavir) is a antiviral medication that is commonly used for the treatment of Hepatitis B specially with patients who have liver damage. This medication is not limited to treating hepatitis B, but it is also used for the treatment of HIV/AIDS and HBV infection. ...

Read More
TOP
<